128 related articles for article (PubMed ID: 19148532)
21. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
22. [Construction of lentivirus producing PLC-gamma1 siRNA and its effect on apoptosis of human colorectal carcinomas cell lines].
Tan L; Luo SQ; Lin J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):255-8. PubMed ID: 17425965
[TBL] [Abstract][Full Text] [Related]
23. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
[TBL] [Abstract][Full Text] [Related]
24. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
Chang SC; Lin PC; Yang SH; Wang HS; Li AF; Lin JK
Ann Surg Oncol; 2009 Aug; 16(8):2323-30. PubMed ID: 19472013
[TBL] [Abstract][Full Text] [Related]
25. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
26. Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: a potential therapeutic target in colorectal cancer.
Matsuda Y; Ishiwata T; Yamahatsu K; Kawahara K; Hagio M; Peng WX; Yamamoto T; Nakazawa N; Seya T; Ohaki Y; Naito Z
Cancer Lett; 2011 Oct; 309(2):209-19. PubMed ID: 21745712
[TBL] [Abstract][Full Text] [Related]
27. Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA.
Sagiv E; Starr A; Rozovski U; Khosravi R; Altevogt P; Wang T; Arber N
Cancer Res; 2008 Apr; 68(8):2803-12. PubMed ID: 18413748
[TBL] [Abstract][Full Text] [Related]
28. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.
Carvalho B; Postma C; Mongera S; Hopmans E; Diskin S; van de Wiel MA; van Criekinge W; Thas O; Matthäi A; Cuesta MA; Terhaar Sive Droste JS; Craanen M; Schröck E; Ylstra B; Meijer GA
Gut; 2009 Jan; 58(1):79-89. PubMed ID: 18829976
[TBL] [Abstract][Full Text] [Related]
29. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells.
Deng H; Ravikumar TS; Yang WL
Cancer Lett; 2009 Aug; 281(2):220-31. PubMed ID: 19321257
[TBL] [Abstract][Full Text] [Related]
31. The 26S proteasome in Schistosoma mansoni: bioinformatics analysis, developmental expression, and RNA interference (RNAi) studies.
Nabhan JF; El-Shehabi F; Patocka N; Ribeiro P
Exp Parasitol; 2007 Nov; 117(3):337-47. PubMed ID: 17892869
[TBL] [Abstract][Full Text] [Related]
32. MAG-2 promotes invasion, mobility and adherence capability of lung cancer cells by MMP-2, CD44 and intracellular calcium in vitro.
Zhang J; Liu G; Meng Y; Lin H; Lu Y
Oncol Rep; 2009 Mar; 21(3):697-706. PubMed ID: 19212629
[TBL] [Abstract][Full Text] [Related]
33. Glucose regulated protein 78 (GRP78) is overexpressed in colorectal carcinoma and regulates colorectal carcinoma cell growth and apoptosis.
Xing X; Li Y; Liu H; Wang L; Sun L
Acta Histochem; 2011 Dec; 113(8):777-82. PubMed ID: 21156321
[TBL] [Abstract][Full Text] [Related]
34. Defective claudin-7 regulation by Tcf-4 and Sox-9 disrupts the polarity and increases the tumorigenicity of colorectal cancer cells.
Darido C; Buchert M; Pannequin J; Bastide P; Zalzali H; Mantamadiotis T; Bourgaux JF; Garambois V; Jay P; Blache P; Joubert D; Hollande F
Cancer Res; 2008 Jun; 68(11):4258-68. PubMed ID: 18519685
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
[TBL] [Abstract][Full Text] [Related]
36. [Expression of FMNL2 and its relation to the metastatic potential of human colorectal cancer cells].
Zhu XL; Liang L; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1775-8. PubMed ID: 18971169
[TBL] [Abstract][Full Text] [Related]
37. Effect of CLN3 silencing by RNA interference on the proliferation and apoptosis of human colorectal cancer cells.
Zhu X; Huang Z; Chen Y; Zhou J; Hu S; Zhi Q; Song S; Wang Y; Wan D; Gu W; Zhou H; Zhang B; Cao W; He S
Biomed Pharmacother; 2014 Apr; 68(3):253-8. PubMed ID: 24556023
[TBL] [Abstract][Full Text] [Related]
38. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
[TBL] [Abstract][Full Text] [Related]
39. Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer.
Huo Q; Kinugasa T; Wang L; Huang J; Zhao J; Shibaguchi H; Kuroki M; Tanaka T; Yamashita Y; Nabeshima K; Iwasaki H; Kuroki M
Anticancer Res; 2009 Mar; 29(3):851-7. PubMed ID: 19414319
[TBL] [Abstract][Full Text] [Related]
40. Interference with netrin-1 and tumor cell death in non-small cell lung cancer.
Delloye-Bourgeois C; Brambilla E; Coissieux MM; Guenebeaud C; Pedeux R; Firlej V; Cabon F; Brambilla C; Mehlen P; Bernet A
J Natl Cancer Inst; 2009 Feb; 101(4):237-47. PubMed ID: 19211441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
